Maternal-Fetal Alloimmune Neutropenia
What is Maternal-Fetal Alloimmune Neutropenia?
Maternal-fetal alloimmune neutropenia is a rare blood condition that affects newborn babies. It happens when a mother's immune system creates antibodies against proteins on her baby's white blood cells. These antibodies cross the placenta during pregnancy and attack the baby's neutrophils, which are a type of white blood cell that fights infections.
The condition causes neutropenia, which means the baby has too few neutrophils in their blood. Most babies with this condition are born appearing healthy. However, low neutrophil counts put newborns at higher risk for bacterial infections during their first weeks of life. The condition typically resolves on its own as the maternal antibodies clear from the baby's system, usually within a few weeks to months.
This condition affects about 1 in 1,000 newborns. It often goes undetected unless the baby develops an infection or routine blood testing reveals low white blood cell counts. Early detection through blood testing helps doctors monitor affected babies and prevent serious infections.
Symptoms
- Frequent or severe bacterial infections in the newborn period
- Skin infections or pustules appearing in the first weeks of life
- Umbilical cord infections that are slow to heal
- Pneumonia or lung infections in newborns
- Fever without an obvious source
- Delayed healing of the umbilical stump
- Oral thrush or mouth infections
Many babies with maternal-fetal alloimmune neutropenia show no symptoms at all. Some babies have mild neutropenia that never causes infections. Symptoms only appear when neutrophil counts drop very low or when the baby encounters bacteria.
Concerned about Maternal-Fetal Alloimmune Neutropenia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Maternal-fetal alloimmune neutropenia happens when a mother's immune system recognizes certain proteins on her baby's neutrophils as foreign. The most common trigger involves human neutrophil antigens, or HNAs, which the baby inherits from the father. If the mother lacks these antigens, her immune system may produce antibodies against them during pregnancy. These antibodies then cross the placenta and destroy the baby's neutrophils.
Risk factors include previous pregnancies where the mother was exposed to different neutrophil antigens. Women who have had multiple pregnancies or blood transfusions may have higher risk because prior exposure increases antibody production. The condition can happen in first pregnancies but becomes more likely with each subsequent pregnancy. Having a different biological father for each pregnancy may increase risk if the new father carries different neutrophil antigens.
How it's diagnosed
Doctors diagnose maternal-fetal alloimmune neutropenia through blood testing in newborns who show signs of infection or have a family history of the condition. A complete blood count measures white blood cell count and neutrophil levels. Low neutrophil counts, typically below 1,000 cells per microliter, suggest neutropenia. Additional specialized tests can detect maternal antibodies against neutrophil antigens in both the mother's and baby's blood.
Rite Aid offers comprehensive blood testing that includes white blood cell count monitoring at Quest Diagnostics locations nationwide. Testing helps identify neutropenia early so doctors can take steps to prevent infections. Regular monitoring through our service allows families to track neutrophil recovery as maternal antibodies clear from the baby's system over time.
Treatment options
- Careful monitoring of white blood cell counts through regular blood testing
- Antibiotic therapy if bacterial infections develop
- Granulocyte colony-stimulating factor, or G-CSF, injections to boost neutrophil production in severe cases
- Intravenous immunoglobulin, or IVIG, to help neutralize maternal antibodies
- Close attention to hygiene and infection prevention in the home
- Limiting exposure to sick contacts during the newborn period
- Prompt medical attention for any signs of fever or infection
- Regular follow-up with a pediatric hematologist until neutrophil counts normalize
Concerned about Maternal-Fetal Alloimmune Neutropenia? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Most cases resolve within 2 to 4 months after birth as maternal antibodies naturally clear from the baby's bloodstream. Some babies recover within a few weeks, while others may take up to 6 months. Regular blood testing helps doctors track when neutrophil counts return to normal levels.
Yes, doctors can detect it through prenatal testing if there is a known family history or concerns from a previous pregnancy. Maternal blood tests can identify antibodies against neutrophil antigens. Fetal blood sampling through cordocentesis can measure neutrophil counts, but this procedure carries risks and is only done in specific situations.
If both parents have the same genetic combination, there is about a 50% chance each future pregnancy will be affected. The risk increases if the father carries the neutrophil antigen that triggered the maternal antibodies. Genetic counseling and prenatal testing can help families understand their specific risk and plan appropriate monitoring.
The condition carries risks but most babies do well with proper monitoring and care. The main danger is bacterial infections when neutrophil counts drop very low. With careful attention to hygiene, prompt treatment of infections, and regular blood count monitoring, serious complications are rare.
Babies most commonly develop skin infections, umbilical cord infections, and pneumonia. Bacterial infections from organisms like Staphylococcus and Streptococcus are typical. Oral thrush and urinary tract infections can also occur. Early recognition and antibiotic treatment prevent these infections from becoming serious.
Testing frequency depends on how low the neutrophil count is and whether infections have occurred. Babies with severe neutropenia may need weekly blood tests initially. As counts improve, testing can be spaced to every 2 to 4 weeks. Your pediatric hematologist will create a monitoring schedule based on your baby's specific situation.
Breastfeeding does not worsen maternal-fetal alloimmune neutropenia and is generally encouraged. While small amounts of antibodies pass through breast milk, they do not significantly affect neutrophil counts. Breast milk actually provides important immune protection that helps babies fight infections during this vulnerable period.
Normal white blood cell counts in newborns range from 9,000 to 30,000 cells per microliter. Neutrophils typically make up 40% to 80% of these white blood cells. In maternal-fetal alloimmune neutropenia, neutrophil counts often drop below 1,000 cells per microliter, which significantly increases infection risk.
Yes, limiting exposure to potential infections is important when neutrophil counts are very low. Ask visitors to wash hands thoroughly and avoid visiting if they have any signs of illness. Avoid crowded places and keep the baby away from anyone with coughs, colds, or other infections during the first few months.
Most babies recover completely with no lasting effects once maternal antibodies clear and neutrophil counts normalize. If severe infections occurred during the newborn period, there could be complications from those infections. However, with proper monitoring and early treatment, the vast majority of affected babies grow into healthy children with normal immune function.